Orthopedic startups chase FDA clearance like it’s the ultimate prize. Years of grinding through R&D, clinical trials, and regulatory hoops lead to that moment of victory when the FDA grants approval. It’s a milestone worth celebrating—a signal to investors and the market that your product has legs. But let’s be clear: FDA clearance isn’t the endgame. It’s a fishing license. Without sales, your startup isn’t a company—it’s just a dream.
FDA Clearance: A Gate, Not a Goal
FDA clearance is a critical step. Whether you’ve developed a next-generation implant, a precision surgical tool, or a digital health solution, that regulatory nod confirms your product is safe and effective. It opens the door to the market and gives investors confidence that you’re on a viable path. For founders, it’s a moment of validation after years of relentless effort.
But validation doesn’t pay for itself. FDA clearance won’t cover salaries, fund your next phase, or make your product a staple in operating rooms. It’s a gate, not a goal—a license to compete, not a guarantee of success. The real challenge begins now: turning that clearance into revenue. Without sales, your startup is a concept, not a business...
